CHEN Fei 1,2 , ZHAO Li 1,2 , GAO Qianqian 1,2 , MEI Fan 1,2 , ZHAO Bing 2 , HU Kaiyan 1,2 , ZHANG Weiyi 2,3 , MA Bin 1,2,4
  • 1. Evidence-Based Nursing Center, School of Nursing, Lanzhou University, Lanzhou 730000, P.R.China;
  • 2. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P.R.China;
  • 3. School of Public Health, Lanzhou University, Lanzhou 730000, P.R.China;
  • 4. Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Department of Pharmacology, School of Basic Medical Science of Lanzhou University, Lanzhou 730000, P.R.China;
MA Bin, Email: kittymb2017@163.com
Export PDF Favorites Scan Get Citation

Objective To systematically investigate the registration status, methodology and reporting quality of the systematic review protocols for animal experiment registered on PROSPERO platform.Methods Systematic review protocols of animal experiments registered on PROSPERO platform were searched up to December 31st, 2019. Two reviewers independently screened literature, extracted data, and performed a descriptive analysis of the methodological quality and reporting characteristics of the included studies.Results A total of 351 protocols from 50 countries were included, involving 22 diseases. The intervention measures were primarily "pharmaceutical chemicals". Only approximately 1/3 of the studies reported the search strategy from at least one database, approximately half of the studies were prepared to report heterogeneity analysis and publication bias, and only approximately 1/3 of the studies were prepared to report sensitivity analysis.Conclusions The quantity of systematic reviews of animal experiments registered on the PROSPERO platform is increasing annually, however, there are still some limitations in the methodology and reporting quality.

Citation: CHEN Fei, ZHAO Li, GAO Qianqian, MEI Fan, ZHAO Bing, HU Kaiyan, ZHANG Weiyi, MA Bin. The methodological and reporting quality of protocols of systematic review on animal experiments: an analysis from PROSPERO platform. Chinese Journal of Evidence-Based Medicine, 2021, 21(1): 77-82. doi: 10.7507/1672-2531.202008045 Copy

  • Previous Article

    Quality assessment of clinical practice guidelines in neonatal field in China
  • Next Article

    Advance and the status quo of the research on applications of prognostic tools in patients with advanced cancer